- POSITIVE
Annual Revenue Shelter Pharma Mar-2026 Annual Revenue is Rs 73 Cr which is growth of 44.4% YoY.
- POSITIVE
Annual Net Profit Shelter Pharma Mar-2026 Annual Net Profit is Rs 9 Cr which is growth of 24.7% YoY.
aboutBased on the corporate reports for the financial year ending March 31, 2025, and subsequent updates, here is a summary of Shelter Pharma Ltd. Shelter Pharma Ltd. is an Indian pharmaceutical company primarily focused on the manufacturing and marketing... Read More
49.002.24(4.79%)
15,000
BSE Volume
BSE 04 Nov, 2026 3:31 PM (IST)
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Shelter Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
26.5% | 26.6% | 73.2 | 50.7 | 40 | 36.2 | 30.1 | 22.5 | 30.1 | 27.8 | 31.5 | 30.8 | ||
Operating Exp. Ann. | 29.1% | 22.1% | 60.4 | 40.6 | 31.5 | 28.1 | 27.1 | 22.3 | 29.8 | 27.6 | 31.3 | 30.7 | |
Operating Profit Ann. | 16.2% | 129.4% | 12.7 | 10.1 | 8.6 | 8.1 | 2.9 | 0.2 | 0.2 | 0.2 | 0.2 | -0.7 | |
OPM Ann. % | -7.9% | 85.1% | 17.40% | 19.87% | 21.41% | 22.29% | 9.72% | 0.80% | 0.73% | 0.64% | 0.50% | -2.26% | |
29.1% | 22.1% | 60.9 | 41 | 31.7 | 28.3 | 27.3 | 22.4 | 30 | 27.7 | 31.4 | 30.8 | ||
EBITDA Ann. | 16.2% | 129.4% | 12.7 | 10.1 | 8.6 | 8.1 | 2.9 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | |
EBITDA Ann. margin % | -7.9% | 84.3% | 17.42% | 19.88% | 21.42% | 22.29% | 9.74% | 0.82% | 0.75% | 0.71% | 0.53% | 0.43% | |
Interest Ann. | - | - | 0.1 | 0.1 | 0.1 | 0 | 0 | ||||||
Depr. | 26% | 32% | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
PBT Ann. | 15.6% | 161.4% | 12.2 | 9.7 | 8.3 | 7.9 | 2.8 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
Tax Ann. | 15.1% | - | 3.2 | 2.4 | 2.1 | 2.1 | 0.9 | 0 | 0 | 0 | 0 | 0 | |
15.8% | 146% | 9 | 7.2 | 6.2 | 5.8 | 1.9 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | ||
Net Profit Ann. | 15.8% | 146% | 9 | 7.2 | 6.2 | 5.8 | 1.9 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
NPM Ann. % | -8.3% | 123.8% | 12.34% | 14.28% | 15.49% | 15.99% | 6.17% | 0.22% | 0.23% | 0.21% | 0.17% | 0.15% | |
EPS Adj. latest Ann. | 16.4% | - | 5.2 | 4.2 | 3.6 | 3.3 | 1.1 | 0 | 0 | 0 | 0 | 0 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
44.4%
2Y CAGR
35.3%
3Y CAGR
26.5%
5Y CAGR
26.6%
7Y CAGR
14.8%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
25%
2Y CAGR
20.5%
3Y CAGR
15.8%
5Y CAGR
146%
7Y CAGR
90.2%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
48.8%
2Y CAGR
38.5%
3Y CAGR
29.1%
5Y CAGR
22.1%
7Y CAGR
11.8%
Operating Expenses Annual Cr growth is higher than historical averages.
Shelter Pharma Technical Analysis
Shelter Pharma EMA & SMA
Bullish+8
8 bullish, 0 bearish
Bullish8
Bearish0
| 5 Day | 45.8 |
|---|---|
| 10 Day | 44.9 |
| 12 Day | 44.7 |
| 20 Day | 43.8 |
| 26 Day | 42.9 |
|---|---|
| 50 Day | 39.6 |
| 100 Day | 36.4 |
| 200 Day | 35.7 |
Shelter Pharma Delivery And Volume
Daily Avg. Delivery Volume %
04 Nov, 2026100.0%
Week100.0%
Month81.9%
Shelter Pharma Active Candlesticks
Marubozu Uptrend Belt Hold Uptrend Closing Marubozu Uptrend Long Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Shelter Pharma Resistance and Support
48.83
Pivot
| First Resistance | 49.2 |
|---|---|
| Second Resistance | 49.3 |
| Third Resistance | 49.7 |
| First Support | 48.7 |
|---|---|
| Second Support | 48.3 |
| Third Support | 48.2 |
| Day RSI | 63.6 |
|---|---|
| Day MACD | 1.8 |
| Day MFI | 25.2 |
| Day MACD Signal Line | 2.1 |
Shelter Pharma Beta
| 1 Month | -0.9 |
|---|---|
| 1 Year | -0.7 |
| 3 Month | -0.2 |
|---|---|
| 3 Year | -0.3 |
Shelter Pharma Price Change Analysis
↑35.2%
Over 1 Month
LowHigh
3755.9
↑84.7%
Over 3 Months
LowHigh
25.155.9
↑61.2%
Over 6 Months
LowHigh
2355.9
↑18.1%
Over 1 Year
LowHigh
2355.9
Shelter Pharma Corporate Actions
Shelter Pharma Dividend history and yield
Shelter Pharma dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Shelter Pharma dividend yield over time.
#Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
123 Sep 2025 | 0.35 | FINAL | 23 Sep 2025 | Equity Share |
223 Sep 2024 | 0.33 | FINAL | - | Equity Share |
Shelter Pharma Board Meetings
Shelter Pharma past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
128 May 2026 | Audited Results | - |
210 Nov 2025 | Half Yearly Results | - |
302 Sep 2025 | A.G.M. & Final Dividend | - |
426 Jun 2025 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Convening of Extra Ordinary General Meeting to take necessary approvals of the Shareholders for Issue of convertible securities as warrants. 2. Other business matters. |
518 Jun 2025 | To consider Fund Raising | - |
Shelter Pharma Corporate Filings
Shelter Pharma BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 04 Nov 2026 | Shelter Pharma Ltd - 543963 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Day 07Th November, 2026 | Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing obligations and Disclosure requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Saturday, 07th November, 2026, at corporate office of the company at 5TH Floor, 501 SAKAR 4, Opp. Town Hall, Ashram Road, Ahmedabad, Gujarat -380006, inter-alia, to consider the following agendas: 1. To consider, approve and take on record the Un-audited Financial Results for the Half year ended on September 30, 2026 as per Regulation 33 of the SEBI (LODR) Regulation, 2015 along with Limited Review report on above Financial Results; 2. Such Other agendas as may be considered necessary with the permission of the chair. | |
| 29 Oct 2026 | Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order | Attached here with order updates recieved on 28.10.2026 | |
| 16 Oct 2026 | Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Allotment | Conversion of Warrants into Equity Shares | |
| 16 Oct 2026 | Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, October 16, 2026 For Conversion Of Warrants Into Equity Shares | Outcome of the Board Meeting held on Friday, October 16, 2026 for conversion of warrants into Equity Shares | |
| 10 Oct 2026 | Shelter Pharma Ltd - 543963 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Attached herewith Compliance Certificate forthe quarter ended 30th September, 2026 |
Shelter Pharma Documents
Shelter Pharma Earnings Call
Shelter Pharma earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 27 Jun 2026 | Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
Shelter Pharma Investor Presentations
Shelter Pharma investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 17 Jun 2026 | Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
Shelter Pharma - Company Profile
Shelter Pharma Management Structure
Shelter Pharma management structure with salaries, total experience, and qualifications.
Shelter Pharma Board of Directors
Shelter Pharma Board of directors with salaries, total experience, and qualifications.
Website: www.shelter.co.in
About the company - Business Profile
Based on the corporate reports for the financial year ending March 31, 2025, and subsequent updates, here is a summary of Shelter Pharma Ltd.
Shelter Pharma Ltd. is an Indian pharmaceutical company primarily focused on the manufacturing and marketing of Ayurvedic and herbal products. The company serves multiple sectors, including human healthcare, veterinary care, and agricultural products. It positions itself as a provider of natural healthcare solutions, leveraging traditional knowledge integrated with modern manufacturing processes.
Key Points
- Key Facts:
- Founded Year: Incorporated in 2007 (originally established as a partnership firm in 1982).
- Headquarters: Himatnagar, Gujarat, India.
- Stock Listing: Listed on the BSE SME platform (Stock Code: 543957).
- Products: A diverse portfolio covering Human (e.g., cough syrups, joint pain oils), Veterinary (e.g., liver tonics, lactation enhancers), and Agri-products (e.g., plant growth promoters).
- Operations and Resources:
- The company operates a manufacturing facility in Himatnagar, Gujarat, which is designed to produce various dosage forms including tablets, capsules, syrups, and ointments.
- The facility adheres to Good Manufacturing Practices (GMP) and is equipped for large-scale production of herbal formulations.
- Market and Significance:
- Shelter Pharma caters to the growing demand for Ayush (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) products both in India and overseas.
- The company maintains a distribution network across several Indian states and has been expanding its footprint in international markets, particularly in South East Asia and Africa.
- Business Model and Competencies:
- Business Model: Operates on a hybrid model of B2B (supplying to distributors and institutions) and B2C (direct retail through its brand).
- Core Competencies: The company excels in formulating herbal remedies for chronic ailments and animal health, where natural alternatives are increasingly preferred over synthetic chemicals.
- Financial Highlights (FY 2024-25):
- Revenue from Operations: ₹40.54 crore (Consolidated).
- EBITDA: ₹3.28 crore.
- Profit After Tax (PAT): ₹1.82 crore.
- Revenue Segmentation: Approximately 65% of revenue is derived from the Human Healthcare segment, 25% from Veterinary products, and the remaining 10% from Agri-products and others.
- Geographical Revenue: Domestic sales account for nearly 88% of total turnover, while exports contribute 12%.
- Strategic Initiatives and Future Outlook:
- Product Development: Recent focus on launching a new range of "Lifestyle Management" products targeting urban health issues like stress and sleep disorders.
- Digital Expansion: The company is increasing its presence on e-commerce platforms to drive direct-to-consumer sales.
- Expansion: Plans are underway to upgrade the current manufacturing unit to meet international regulatory standards (such as PIC/S) to further boost export opportunities.
- Employee and Organizational Structure:
- Employee Count: The company employs approximately 150 permanent staff members.
- Subsidiaries: Shelter Pharma has no major active subsidiaries as of the latest reporting period; it operates primarily as a standalone entity.